Good Tissue Practice (GTP)

To prevent the introduction, transmission, and contamination of infectious diseases owing to the utilization of products/techniques related to human tissue, the Department of Health of the Executive Yuan, which is now the Ministry of Health and Welfare (MOHW), enacted a regulation called 'Good Practice for Human Cells and Tissues' on December 13, 2002, which is also known as GTP.

GTP regulates the manufacturing process to ensure human cells and tissues do not contain pathogens, and do not affect the utility of human cell and tissue-based products due to improper operation.

Under strict control, medical products can achieve the goal of safety, effectiveness, and consistency.

GWOXI Stem Cell R&D Center
Gwo Xi Stem Cell Company is committed to developing novel stem cell medicines. Based on the attributes of each stem cell medicines, we have established multiple GTP laboratories by adopting modular production design in our center. The verified processes include human tissue tests, tissue collection, cell preparation, cell storage, product package, label, and delivery.

All equipments meet the requirements of DQ (Design and Development Qualification), IQ (Installation Qualification), OQ (Operation Qualification), and PQ (Performance Qualification).

The safety, effectiveness, and consistency have been verified several times by competent authority-auditor onsite visits over years.